Search results for "xbridge"
Results per page
10000 Results Found | Selected Filters:
bioMérieux receives IVDR Class D CE marking for BIOFIRE Respiratory 2.1 plus Panel & BIOFIRE FILMARRAY Pneumonia plus Panel
The first syndromic tests including MERS-CoV to achieve this certification
Rethinking solid support chemistry for scalable siRNA manufacturing
Dr. Catherine McKeen of LGC Diagnostics & Genomics - Biosearch Technologies Oligo Synthesis explains how solid support chemistry influences oligonucleotide yield and purity, and how customer collaboration shaped the development of PrimeMax™ CPG
Leica Biosystems introduces new high-speed laser cassette printer
HistoCore LIGHTNING C Laser Cassette Printer helps laboratories improve specimen identification and tracking while reducing costs
Microplastics in drinking water
Fujirebio expands access to blood-based neurology testing in Brazil
Brazilian Health Regulatory Agency (ANVISA) has given market authorization for Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma
Managing AI risk in the clinical laboratory
The same AI tools that are speeding up diagnosis in the clinical lab are also arming the people trying to break into it
Exclusive trade-in savings on trusted dairy solutions
CRP, ESR and PV – A comparative review
This guest editorial features insights from Consultant Biomedical Scientist David Norcliffe, Advanced Clinical Practitioner David Manuel, and Bernie Benson, Founder of Benson Viscometers, on selecting inflammatory markers for clinical diagnostics
Cytek and Sysmex Europe team up to expand access to advanced clinical flow cytometry
Complementary technologies deliver an integrated, end-to-end clinical flow cytometry workflow for laboratories across Europe
Advancing Alzheimer’s diagnostics at Quanterix with multi-marker testing
Exploring the next phase of Alzheimer’s diagnostics from AAIC 2026
SpectraMax iD series enhanced readers
Bracco expands BubbleGen cell selection with CD3+ T Cell Isolation Kit
Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development
Making Alzheimer’s testing more accessible with blood-based biomarkers
AAIC 2026 interview with Beckman Coulter Diagnostics
CMC has a knowledge-continuity problem, not a data problem
Connected data and traceable decisions are becoming vital in a new era of pharmaceutical development, AI, and advanced therapies
























